The requirements of the Drug Supply Chain Security Act (DSCSA) allow certain medications to be:
Tracked and traced.
The Drug Supply Chain Security Act (DSCSA) establishes requirements for the secure tracking and tracing of prescription medications throughout the supply chain. This ensures that drugs can be monitored for safety and authenticity, reducing the risk of counterfeit products reaching consumers.
While medications can sometimes be discounted before being dispensed, this option does not reflect any specific requirements set forth by the DSCSA. The act focuses on security measures rather than pricing or dispensing procedures, making this choice irrelevant in the context of the law's objectives.
The DSCSA specifically mandates that prescription medications be tracked and traced throughout the supply chain. This includes maintaining detailed records of each transaction involving prescription drugs, which is crucial for ensuring safety, preventing counterfeiting, and facilitating recalls if necessary. This is the core purpose of the legislation.
The terms "appealed" and "approved" relate more to the regulatory approval process for new drugs rather than the specific requirements of the DSCSA. This option does not address the act's focus on the security and traceability of drugs after they have been approved for market use.
While all medications must be prescribed and processed within the healthcare system, this option does not pertain to the unique objectives of the DSCSA. The act is concerned with the tracking and tracing of medications once they are in the supply chain, not the initial prescribing or processing methods.
The Drug Supply Chain Security Act's primary focus is on the ability to track and trace medications throughout the supply chain, ensuring their safety and authenticity. Options A, C, and D do not align with the core requirements of the DSCSA, which emphasizes security measures rather than financial, approval, or processing aspects. By mandating tracking and tracing, the DSCSA contributes significantly to public health and safety in medication distribution.
Related Questions
View allCaduet is a combination of amlodipine and:
It would be appropriate for a pharmacy to perform a root-cause analysi...
Which of the following is a potential adverse effect of warfarin?
Which of the following is a Schedule IV controlled substance?
Which of the following is an angiotensin-converting enzyme inhibitor?
Related Quizzes
View allPharmacy Technician Certification Exam PTCE
PTCE Pharmacy Technician Certification Exam
PTCE Blue Print for Pharmacy Technician Certification
Pharmacy Technician Certification Exam PTCE Blueprint
Pharmacy Technician Certification Exam PTCE Practice Questions
Master The Pharmacy Technician Certification Exam PTCE
Pharmacy Technician Certification Exam Answers
PTCE With Online Test Pharmacy Technician Certification Exam
Certified Pharmacy Technician Certification
Pharmacy Technician Certification Exam Practice Test
- ✓ 500+ Practice Questions
- ✓ Detailed Explanations
- ✓ Progress Analytics
- ✓ Exam Simulations